VRDN-002
VRDN-002 is a human monoclonal antibody (mAb) targeting IGF1R/CD221. VRDN-002 reduces inflammation and proptosis in thyroid eye disease (TED) . VPI-2690B can be used in Graves ophthalmopathy research[1].
Product Specifications
UNSPSC
12352203
Target
IGF-1R
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[VRDN-002]
References & Citations
[1]Dickinson B. VRDN-002, a second-generation insulin like growth factor-1 receptor (IGF-1R) inhibitory antibody for thyroid eye disease: Preclinical pharmacokinetics and clinical promise[J]. Investigative Ophthalmology & Visual Science, 2022, 63 (7) : 3995–A0337-3995–A0337.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx151721-01 96 Tests
Human G Protein Coupled Receptor, Family C, Group 5, Member A (GPRC5A) ELISA Kit
Ask
View Details abx151721-02 5x 96 Tests
Human G Protein Coupled Receptor, Family C, Group 5, Member A (GPRC5A) ELISA Kit
Ask
View Details 
abx151721-03 10x 96 Tests
Human G Protein Coupled Receptor, Family C, Group 5, Member A (GPRC5A) ELISA Kit
Ask
View Details 031463-ML490 100 µL
AADAT, ID (AADAT, KAT2, Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial, 2-aminoadipate aminotransferase, 2-aminoadipate transaminase, Alpha-aminoadipate aminotransferase, Kynurenine aminotransferase II, Kynurenine-oxoglutarate aminotransferase II, Kynurenine-oxoglutarate transaminase 2, Kynurenine-oxoglutarate transaminase II) (MaxLight 490) discontinued
Ask
View Details